TNF and uveitis: In conclusion, our experience with adalimumab has been positive, leading to the control of both arthritis and uveitis in a child with psoriatic JIA complicated by uveitis, which was resistant to previous treatments with NSAIDs, DMARDs, and initial TNF inhibitor therapy etanercept.